# Flow Cytometry Core

> **NIH NIH P30** · RHODE ISLAND HOSPITAL · 2024 · $208,074

## Abstract

Flow Cytometry Core
Abstract
The Flow Cytometry Core was initially formed to fulfill the flow cytometry needs of the projects and pilot projects
of the original COBRE Phase I application. The Core provided expertise in stem cell and rare cell separations,
cell sorting and cell phenotyping analysis, by making available, state-of-the-art instrumentation for the flow
cytometry needs of the COBRE investigators as well as the clinical and basic research community in Rhode
Island. Today, the Flow Cytometry Core continues to fulfill this critical role and supports a multitude of research
programs, projects and diverse research areas at Rhode Island Hospital and different institutions in the state of
Rhode Island. It remains heavily utilized, partially due to the strong support and success of the COBRE’s here
in Rhode Island but also the strategic importance and basic relevance that flow cytometry brings to the research
community at large. This is the only research flow cytometry core facility at Rhode Island Hospital and the only
research flow cytometry core facility that offers access to a 5-laser sorter, 4-laser analyzer and a mass cytometer
in the state. Flow cytometry remains an extremely useful tool for researchers over many different research
disciplines. The institution has been generous with its administrative and fiscal support of the Flow Cytometry
Core. Notably, this year Rhode Island Hospital has purchased and installed, a Fluidigm Helios CyTOF system,
that is now available through the COBRE Flow Cytometry Core. This CyTOF platform will be utilized by clinical
and basic researchers in the State of Rhode Island and shows a high level of support and dedication to the
success of the proposed COBRE Flow Cytometry Core. With the new state-of-the-art instrumentation and Core
expansion plan directed towards expanding inclusion of clinical research projects, our Core is well positioned to
continue its growth and achieve long-term financial sustainability.

## Key facts

- **NIH application ID:** 10874431
- **Project number:** 5P30GM145500-02
- **Recipient organization:** RHODE ISLAND HOSPITAL
- **Principal Investigator:** MARK S DOONER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $208,074
- **Award type:** 5
- **Project period:** 2023-07-01 → 2028-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10874431

## Citation

> US National Institutes of Health, RePORTER application 10874431, Flow Cytometry Core (5P30GM145500-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10874431. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*